AAAAAA

   
Results: 1-25 | 26-39 |
Results: 26-39/39

Authors: Van Basten, JPA Van Driel, MF Hoekstra, HJ Sleijfer, DT Van de Wiel, HBM Droste, JHJ Koops, HS Mensink, HJA
Citation: Jpa. Van Basten et al., Objective and subjective effects of treatment for testicular cancer on sexual function, BJU INT, 84(6), 1999, pp. 671-678

Authors: Sonneveld, DJA Hoekstra, HJ Van Der Graaf, WTA Sluiter, WJ Koops, HS Sleijfer, DT
Citation: Dja. Sonneveld et al., The changing distribution of stage in nonseminomatous testicular germ celltumours, from 1977 to 1996, BJU INT, 84(1), 1999, pp. 68-74

Authors: Sonneveld, DJA Sleijfer, DT Koops, HS Sijmons, RH van der Graaf, WTA Sluiter, WJ Hoekstra, HJ
Citation: Dja. Sonneveld et al., Familial testicular cancer in a single-centre population, EUR J CANC, 35(9), 1999, pp. 1368-1373

Authors: Rodenhuis, S de Wit, R de Mulder, PHM Keizer, HJ Sleijfer, DT Lalisang, RI Bakker, PJM Mandjes, I Kooi, M de Vries, EGE
Citation: S. Rodenhuis et al., A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission, ANN ONCOL, 10(12), 1999, pp. 1467-1473

Authors: Schroder, CP de Vries, EGE Muder, NH Willemse, PHB Sleijfer, DT Hospers, GAP van der Graaf, WTA
Citation: Cp. Schroder et al., Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B, J ANTIMICRO, 43(5), 1999, pp. 741-743

Authors: Meinardi, MT van der Graaf, WTA van Veldhuisen, DJ Gietema, JA de Vries, EGE Sleijfer, DT
Citation: Mt. Meinardi et al., Detection of anthracycline-induced cardiotoxicity, CANC TR REV, 25(4), 1999, pp. 237-247

Authors: de Vries, EGE Mulder, NH Sleijfer, DT
Citation: Ege. De Vries et al., Medical oncology in the next century, NETH J MED, 55(6), 1999, pp. 310-315

Authors: Raghoebar-Krieger, HMJ Sleijfer, DT Kreeftenberg, HG Hofstee, WKB Bender, W
Citation: Hmj. Raghoebar-krieger et al., Objectives for an internship internal medicine: from the Dutch Blueprint (Raamplan 1994) to implementation into a practical logbook, NETH J MED, 55(4), 1999, pp. 168-176

Authors: Nijhuis, PHA Pras, E Sleijfer, DT Molenaar, WM Koops, HS Hoekstra, HJ
Citation: Pha. Nijhuis et al., Long-term results of preoperative intra-arterial doxorubicin combined withneoadjuvant radiotherapy, followed by extensive surgical resection for locally advanced soft tissue sarcomas of the extremities, RADIOTH ONC, 51(1), 1999, pp. 15-19

Authors: de Graaff, WE van Echten, J van der Veen, AY Sleijfer, DT Timmer, A Koops, HS de Jong, B
Citation: We. De Graaff et al., Loss of the Y-chromosome in the primary metastasis of a male sex cord stromal tumor: Pathogenetic implications, CANC GENET, 112(1), 1999, pp. 21-25

Authors: van Echten, J Timmer, B Dam, A Sleijfer, DT Koops, HS de Jong, B
Citation: J. Van Echten et al., Cytogenetic analysis of a mature teratoma and a yolk sac tumor component of a late relapse of a disseminated testicular nonseminoma, CANC GENET, 111(1), 1999, pp. 49-54

Authors: Huizinga, GA Sleijfer, DT van de Wiel, HBM van der Graaf, WTA
Citation: Ga. Huizinga et al., Decision-making process in patients before entering phase III cancer clinical trials: A pilot study, CANCER NURS, 22(2), 1999, pp. 119-125

Authors: Sonneveld, DJA Schaapveld, M Sleijfer, DT Meerman, GJT van der Graaf, WTA Sijmons, RH Koops, HS Hoekstra, HJ
Citation: Dja. Sonneveld et al., Geographic clustering of testicular cancer incidence in the northern part of The Netherlands, BR J CANC, 81(7), 1999, pp. 1262-1267

Authors: de Jong, RS Mulder, NH Uges, DRA Sleijfer, DT Hoppener, FJP Groen, HJM Willemse, PHB van der Graaf, WTA de Vries, EGE
Citation: Rs. De Jong et al., Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin, BR J CANC, 79(5-6), 1999, pp. 882-887
Risultati: 1-25 | 26-39 |